Endocrinology and Metabolism Has Been Indexed in MEDLINE: A Major Achievement

Abstract

Endocrinology and Metabolism (EnM, pISSN 2093-596X, eISSN 2093-5978, https://www.e-enm.org), which is the official journal of the Korean Endocrine Society (http://www.endocrinology.or.kr), was indexed in MEDLINE in March 2019. I am delighted to share this news with the readers, authors, reviewers, and editors of EnM. Specifically, the Literature Selection Technical Review Committee (LSTRC) of MEDLINE informed me on March 22, 2019 that EnM has been accepted for inclusion in MEDLINE. In my opinion, this is a major achievement in our journey toward becoming a renowned international journal in the field of endocrinology and metabolism. A National Institutes of Health (NIH)–chartered advisory committee, the LSTRC evaluates and recommends journals for MEDLINE. The LSTRC considers the quality of the scientific content of a journal, including its originality. A special feature of MEDLINE is that it uses Medical Subject Headings (MeSH) to index citations. We, the editors of EnM, devoted ourselves to the goal of making EnM a MEDLINE journal in order to establish it as a significant platform for the exchange of up-to-date knowledge in the field of endocrinology. Therefore, I would like to present a brief summary of the recent progress that EnM has made. We added the credentials and affiliations of the editorial board members to our website, including their Researcher IDs and Open Researcher and Contributor ID (ORCID) identifiers [1]. We also improved the editorial quality of EnM by implementing a high-quality system for English-language editing and statistical review. Every manuscript is published after close examination by statistical editors, manuscript editors, and a professional English editing company (Compecs Inc., Seoul, Korea). We consolidated our ethics regulations and have made efforts to comply with all ethical guidelines recommended by the International Committee of Medical Journal Editors (ICMJE). Editorial policies and best practices are described on the EnM homepage and are actively implemented. The acceptance rate of unsolicited manuscripts has been lowered to 44% for the most recent 2 years. We have published increasingly more high-quality articles, such as randomized controlled trials, meta-analyses, and systemic reviews. We expect EnM to be essential reading for policy-makers who are interested in health problems that are still incompletely understood or environmental health threats such as endocrine disruptors, as we are publishing important articles in this field [2,3]. The scope of our journal has been widened to include authors from throughout the world. Articles by authors from 32 countries on 6 continents have been published in EnM in recent 6 years, and investigators from 51 countries have submitted manuscripts. EnM has shown an steep increase in Scimago Journal Rank (SJR) which was 0.766 in 2016, and 1.12 in 2017. The editorial board of EnM includes world-renowned scientists who have published papers in major journals such as Cell, Nature, and NEJM as principal authors, and many of them are editorsin-chief of other major endocrine journals. EnM has been indexed in the EBSCO database since 2012,